Skip to main content
TEVNF logo

Tevano Systems Holdings Inc (TEVNF) Stock Price & Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.00001 $0.00 (0.00%)
Vol: 3.0K| 52-wk range: $0.000001 – $0.0042
Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Tevano Systems Holdings Inc (TEVNF) trades at $0.00001. Tevano Systems Holdings Inc. is a Canadian technology company focused on developing and distributing electronic devices, notably the AI-driven Health Shield for immediate body temperature readings and mask advisories. Sector: Technology.

Price as of · Last analyzed: Jun 15, 2026
Tevano Systems Holdings Inc. is a Canadian technology company focused on developing and distributing electronic devices, notably the AI-driven Health Shield for immediate body temperature readings and mask advisories. Operating on the OTC Other tier with an exceptionally small market capitalization, the company faces significant financial instability despite its focus on high-growth technology development.

Analyst Coverage for TEVNF: TEVNF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

▶ Watch the TEVNF film Every key number, told as a short cinematic story — just press play. ~2 min

No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.

Tevano Systems Holdings Inc (TEVNF) Technology Profile & Competitive Position

CEOStephen Brown
Employees700
HeadquartersVancouver, CA
IPO Year2021

Tevano Systems Holdings Inc. develops AI-driven electronic health devices, including the Health Shield for temperature screening and mask advisories, positioning itself in the medical instruments and supplies sector. Headquartered in Vancouver, Canada, the company focuses on technology development amidst an extremely low market capitalization and significant financial challenges.

Data Provenance | Financial Data Quantitative Analysis Analysis: Jun 15, 2026

What Is the Investment Thesis for TEVNF?

AI-written as of Jun 15, 2026 — figures and tone reflect the data available then, not today's score.

Tevano Systems Holdings Inc. presents an investment profile characterized by both high-potential technological focus and significant financial instability. The company's core strength lies in its dedication to technology development, particularly in AI-driven health devices like the Health Shield, which operates in the high-growth healthcare technology sector. This focus offers a pathway to potential market relevance through innovative solutions for public health monitoring. However, the company's financial metrics reveal substantial challenges, including an exceptionally small market capitalization of $744, a profit margin of -166572.2%, and a gross margin of -92.0%. These figures are indicative of a company in a very early stage or facing severe operational difficulties, highlighting a critical need for securing substantial funding and achieving sustainable revenue generation. The negative Beta of -2.70 suggests an inverse relationship with market movements, which could be due to its micro-cap nature and specific operational factors. For investors, the thesis hinges on the company's ability to overcome its current financial fragility and successfully commercialize its technological developments, transforming its potential into tangible financial performance.

Based on FMP financials and quantitative analysis

TEVNF Key Highlights

AI-written as of Jun 15, 2026 — figures and tone reflect the data available then, not today's score.

Market Capitalization of $0.00B ($744), indicating an exceptionally small enterprise value and potential financial instability.

  • Profit Margin of -166572.2%, reflecting significant unprofitability and substantial operational losses.
  • Gross Margin of -92.0%, suggesting that the cost of goods sold far exceeds revenue, highlighting severe challenges in product pricing or production efficiency.
  • Beta of -2.70, indicating an inverse and highly volatile relationship with the broader market, which is unusual and may be attributed to its micro-cap status and specific company-level factors.
  • Focus on AI-driven electronic device development, particularly the Health Shield, positioning the company in the high-growth healthcare technology sector.

Who Are TEVNF's Competitors?

TEVNF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
SAP SAP SE $208.57 -1.05% $243B 85 5-pillar
SHOP Shopify Inc. $159.77 +5.54% $207B 76 5-pillar
CRM Salesforce, Inc. $229.78 -2.09% $188B 73 5-pillar
UBER Uber Technologies, Inc. $69.48 +2.01% $141B 72 5-pillar
DDOG Datadog, Inc. $279.12 +0.69% $99.4B 70 5-pillar
CDNS Cadence Design Systems, Inc. $354.27 +0.83% $97.6B 76 5-pillar
APP AppLovin Corporation $281.97 +5.13% $94.7B 96 5-pillar
INTU Intuit Inc. $282.80 +0.61% $77.4B 82 5-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are TEVNF's Key Strengths?

Focus on AI-driven technology development, aligning with high-growth potential sectors.

  • Health Shield offers a specific, relevant solution for public health monitoring (temperature and mask advisories).
  • Positioned in the expanding healthcare technology and medical instruments industry.
  • Canadian headquarters provides a stable base for operations.

What Are TEVNF's Weaknesses?

Extremely low market capitalization ($744) indicates significant financial instability and limited resources.

  • Severe unprofitability with a profit margin of -166572.2% and gross margin of -92.0%.
  • Unknown disclosure status on the OTC market, limiting transparency for investors.
  • Reliance on securing external funding to achieve revenue generation and sustain operations.

What Are the Key Risks for TEVNF?

Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.

  • **Extreme Financial Instability and Unprofitability.** With a market capitalization of $744, a profit margin of -166572.2%, and a gross margin of -92.0%, the company faces severe financial challenges, raising significant concerns about its long-term viability and ability to sustain operations.
  • **Challenges in Securing Adequate Funding.** The explicit need to secure funding, coupled with the company's current financial state, indicates a substantial risk that it may not be able to raise sufficient capital to support its operations and commercialization efforts, potentially leading to business failure.
  • **Limited Market Acceptance and Competition.** Despite the high-growth potential of healthcare technology, the market for AI-driven health devices is competitive. There is a risk that Health Shield may not gain significant market traction or could be outcompeted by more established or better-funded rivals.
  • **Lack of Transparency Due to Unknown Disclosure Status.** Trading on the OTC Other tier with an unknown disclosure status presents a significant risk to investors, as the absence of regular financial reporting and public information makes informed decision-making extremely difficult and increases speculative risk.
  • **Operational Challenges in Scaling Production and Distribution.** Even if funding is secured, scaling the production, marketing, and distribution of electronic devices, particularly in the medical sector which has regulatory hurdles, can be complex and costly, posing a risk to efficient commercialization.

What Threats Does TEVNF Face?

  • Intense competition from established medical device manufacturers and other tech companies.
  • Challenges in securing adequate funding to support R&D, production, and market entry.
  • Regulatory hurdles and compliance requirements for medical devices.
  • Rapid technological advancements potentially rendering current products obsolete.
  • Low liquidity and high volatility associated with OTC Other tier trading.

What Are TEVNF's Competitive Advantages?

  • Proprietary AI technology integrated into its Health Shield device for specific health advisories.
  • Early mover advantage in combining immediate temperature readings with mask compliance advisories in a single device.
  • Focus on a niche market within public health and safety technology.
  • Potential for specialized intellectual property related to its AI algorithms and device design.

What Does TEVNF Do?

Tevano Systems Holdings Inc. is a technology development company based in Vancouver, Canada, specializing in the creation and distribution of electronic devices for various industries, with a notable focus on healthcare. The company's flagship product, Health Shield, exemplifies its commitment to leveraging artificial intelligence for practical health solutions. This AI-driven electronic gadget is designed to perform immediate body temperature readings, providing a rapid assessment tool for public health and safety protocols. Beyond temperature detection, Health Shield also advises users on the necessity of wearing a face mask, integrating a crucial public health recommendation directly into its functionality. This dual capability positions Health Shield as a relevant device in environments requiring enhanced health monitoring and compliance, such as commercial spaces, educational institutions, or public transportation hubs. Tevano Systems Holdings Inc. operates within the broader technology sector, aiming to commercialize its innovations. While its current market capitalization is exceptionally small, indicating a nascent stage of development or significant financial hurdles, the company's strategic emphasis on technology development, particularly in AI-driven health solutions, aligns with areas of high growth potential within the healthcare technology landscape. The company's operational structure is centered on bringing these electronic devices from concept to market, with its corporate headquarters serving as the hub for its development and distribution efforts.

What Products and Services Does TEVNF Offer?

  • Develops and distributes electronic devices.
  • Specializes in AI-driven gadgets for health monitoring.
  • Offers Health Shield, an AI device for immediate body temperature readings.
  • Health Shield advises users on the necessity of wearing a face mask.
  • Focuses on technology development and commercialization for various industries.
  • Maintains corporate headquarters in Vancouver, Canada.

How Does TEVNF Make Money?

  • Sells electronic devices, such as Health Shield, directly to businesses, institutions, or potentially consumers.
  • Generates revenue from the sales of its AI-driven health monitoring products.
  • Focuses on commercializing its developed technologies to achieve revenue generation.

What Industry Does TEVNF Operate In?

Tevano Systems Holdings Inc. operates within the Medical - Instruments & Supplies industry, a segment of the broader Healthcare sector characterized by innovation in diagnostic, monitoring, and therapeutic devices. This industry is experiencing significant growth driven by technological advancements, an aging global population, and increased focus on preventative care and public health safety. Tevano's Health Shield, an AI-driven device for temperature readings and mask advisories, positions the company within the niche of smart health monitoring and public safety solutions. While the overall market for medical instruments is robust, Tevano's extremely small market capitalization and negative financial margins suggest it is a very nascent or struggling player. The competitive landscape includes established medical device manufacturers and emerging tech companies developing similar health-screening technologies. Success in this environment often requires substantial R&D investment, regulatory approvals, and effective market penetration strategies.

Who Are TEVNF's Key Customers?

  • Businesses requiring health screening solutions for employees and customers.
  • Public institutions and facilities (e.g., schools, government buildings) implementing health safety protocols.
  • Organizations seeking automated solutions for temperature checks and mask compliance.
  • Potentially individual consumers interested in personal health monitoring devices.
Model self-rating on this text: 64% (not a measure of the evidence) Updated: Jun 15, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● No usable price
  • ● No filing on record
  • ● No analyst coverage
ROE 322%

Key Financial Metrics

Return on equity for Tevano Systems Holdings Inc stands at 322.4%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -26.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.03 means current liabilities exceed short-term assets, a liquidity point worth watching.

Company Profile

Tevano Systems Holdings Inc operates in the Technology sector. It is headquartered in Vancouver, CA. TEVNF has traded publicly since 2021.

F-Score 3/9

Financial Health

Tevano Systems Holdings Inc's Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.

TEVNF Financials

Fundamental Snapshot

Return on Equity (TTM)
+322.4%
Current Ratio
0.0

Based on FMP financials and quantitative analysis

TEVNF Latest News

TEVNF Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for TEVNF.

Price Targets

Wall Street price target analysis for TEVNF.

TEVNF MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for TEVNF; grades run from A+ (80-100) to F (below 30).

Leadership: Stephen Brown

Chief Executive Officer

Stephen Brown serves as the Chief Executive Officer of Tevano Systems Holdings Inc. His involvement suggests a background in technology, business development, or executive management, crucial for guiding a company in the innovative yet challenging field of medical instruments and supplies.

Track Record: Under Stephen Brown's leadership, Tevano Systems Holdings Inc. has focused on the development of its flagship product, Health Shield, an AI-driven device for temperature readings and mask advisories. His tenure has been marked by the company's commitment to technology development in a high-growth potential area. Key strategic decisions likely include the emphasis on AI integration and targeting the public health monitoring market, despite the company's current financial challenges and extremely small market capitalization.

TEVNF OTC Market Information

Tevano Systems Holdings Inc. trades on the OTC Other tier, which is the lowest and most speculative tier of the OTC Markets. Unlike companies listed on major exchanges like NYSE or NASDAQ, which have stringent listing requirements regarding financial health, public float, and governance, OTC Other companies face minimal standards. This tier typically includes shell companies, companies in financial distress, or those with limited public information. It signifies a higher risk profile for investors due to less oversight and often less transparent operations compared to higher OTC tiers like OTCQX or OTCQB, which have more robust disclosure requirements.

  • OTC Tier: OTC Other
Liquidity: Given Tevano Systems Holdings Inc.'s exceptionally small market capitalization of $744 and its OTC Other tier classification, liquidity is likely extremely low. Trading volume may be minimal, leading to wide bid-ask spreads and significant price volatility. Investors may find it difficult to buy or sell shares without substantially impacting the stock price, and there might be delays in executing trades. This illiquidity poses a substantial risk, as it can be challenging to exit a position quickly or at a desired price.
OTC Risk Factors:
  • Extremely low market capitalization and potential financial instability, indicating a high risk of business failure.
  • Unknown disclosure status, leading to a severe lack of transparency and difficulty in assessing fundamental value.
  • Limited liquidity and wide bid-ask spreads, making it challenging to trade shares efficiently.
  • Higher susceptibility to fraud and manipulation due to less regulatory oversight compared to major exchanges.
  • Potential for delisting or further deterioration of trading status if disclosure or financial conditions do not improve.
Due Diligence Checklist:
  • Verify any available financial statements and audit reports, even if disclosure status is unknown.
  • Research any news or press releases from the company, independent of official filings, to gauge activity.
  • Assess the current operational status and actual commercialization efforts of Health Shield.
  • Investigate management's background and track record beyond what is publicly stated.
  • Understand the company's capital structure, outstanding shares, and potential for dilution.
  • Evaluate the competitive landscape and market acceptance of its products.
  • Consider the potential for future funding rounds and their impact on existing shareholders.
Legitimacy Signals:
  • Existence of a specific product (Health Shield) with a clear description of its functionality.
  • Stated focus on technology development in a high-growth sector (AI-driven health devices).
  • Identified corporate headquarters in Vancouver, Canada, providing a physical presence.
  • Named CEO (Stephen Brown) indicates a formal leadership structure.

What Investors Ask About Tevano Systems Holdings Inc (TEVNF) — Technology

How does Tevano Systems Holdings Inc. plan to achieve revenue generation and secure funding?

Based on available insights, Tevano Systems Holdings Inc. is focused on technology development and commercialization across various industries, with Health Shield being a key product.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

MoonshotScore is not published for this security.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Limited financial data available beyond basic margins and market cap.
  • Specific details on CEO background and tenure are not provided in the source.
  • Growth opportunities are inferred based on the product description and industry context, as specific company growth plans are not detailed.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis